Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Lori

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Expert Review of Vaccines|October 13, 2011
DermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDSFranco Lori
Current Opinion in HIV and AIDS|April 18, 2009
Treating HIV/AIDS by reducing immune system activation: the paradox of immune deficiency and immune hyperactivationFranco Lori
Expert Opinion on Biological Therapy|July 2, 2003
2nd International Symposium on Molecular Diagnostics and Skin Gene TherapyJulianna Lisziewicz, Franco Lori
Microbes and Infection|March 7, 2002
Structured treatment interruptions in HIV/AIDS therapyJulianna Lisziewicz, Franco Lori
Current Drug Delivery|February 14, 2006
Topical DermaVir vaccine targeting dendritic cellsJulianna Lisziewicz, Laurene Kelly, Franco Lori
Journal of Immunological Methods|May 10, 2003
Vaccinia assay for the rapid detection of functional HIV-specific CD8+ cytotoxic T lymphocytesJianqing Xu, Franco Lori, Julianna Lisziewicz
Current Opinion in HIV and AIDS|April 18, 2009
Stopping HAART temporarily in the absence of virus rebound: exploring new HIV treatment optionsFranco Lori, Andrea Foli, Julianna Lisziewicz
The Journal of Antimicrobial Chemotherapy|August 6, 2002
Structured treatment interruptions as a potential alternative therapeutic regimen for HIV-infected patients: a review of recent clinical data and future prospectsFranco Lori, Andrea Foli, Julianna Lisziewicz
Vaccine|January 18, 2003
Therapeutic vaccination for future management of HIV/AIDSJulianna Lisziewicz, Nyasha Bakare, Franco Lori
Expert Opinion on Biological Therapy|October 6, 2007
The potential of topical DNA vaccines adjuvanted by cytokinesJulianna Lisziewicz, Sandra A Calarota, Franco Lori
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Expert Review of Vaccines|October 13, 2011
DermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDSFranco Lori
Current Opinion in HIV and AIDS|April 18, 2009
Treating HIV/AIDS by reducing immune system activation: the paradox of immune deficiency and immune hyperactivationFranco Lori
Expert Opinion on Biological Therapy|July 2, 2003
2nd International Symposium on Molecular Diagnostics and Skin Gene TherapyJulianna Lisziewicz, Franco Lori
Microbes and Infection|March 7, 2002
Structured treatment interruptions in HIV/AIDS therapyJulianna Lisziewicz, Franco Lori
Current Drug Delivery|February 14, 2006
Topical DermaVir vaccine targeting dendritic cellsJulianna Lisziewicz, Laurene Kelly, Franco Lori
Journal of Immunological Methods|May 10, 2003
Vaccinia assay for the rapid detection of functional HIV-specific CD8+ cytotoxic T lymphocytesJianqing Xu, Franco Lori, Julianna Lisziewicz
Current Opinion in HIV and AIDS|April 18, 2009
Stopping HAART temporarily in the absence of virus rebound: exploring new HIV treatment optionsFranco Lori, Andrea Foli, Julianna Lisziewicz
The Journal of Antimicrobial Chemotherapy|August 6, 2002
Structured treatment interruptions as a potential alternative therapeutic regimen for HIV-infected patients: a review of recent clinical data and future prospectsFranco Lori, Andrea Foli, Julianna Lisziewicz
Vaccine|January 18, 2003
Therapeutic vaccination for future management of HIV/AIDSJulianna Lisziewicz, Nyasha Bakare, Franco Lori
Expert Opinion on Biological Therapy|October 6, 2007
The potential of topical DNA vaccines adjuvanted by cytokinesJulianna Lisziewicz, Sandra A Calarota, Franco Lori
Pageof 5